In the UK, hospital discharges for hyperplasia of the prostate are forecasted to decline annually from 2024 to 2028, starting at 18.65 thousand in 2024 and expected to reach 17.4 thousand by 2028. In 2023, the actual number of discharges stood at 18.93 thousand. The year-on-year decline averages at approximately 1.7%. Looking over a longer period, the compound annual growth rate (CAGR) from 2024 to 2028 is forecasted to be around -1.7% indicating a consistent decrease in hospital discharges.
Future trends to watch include advancements in medical treatments and technological innovations in prostate care, which could influence hospital discharge rates as less invasive procedures gain popularity. Changes in healthcare policies and demographic shifts, such as an aging population, may also impact discharge trends.
